Short and long term immunosuppressive effects of clozapine and haloperidol (Q48645845)

13 February 2018

title

Short and long-term immunosuppressive effects of clozapine and haloperidol (English)

1 reference

13 February 2018

Short and long term immunosuppressive effects of clozapine and haloperidol (English)

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

14 November 2024

I. Leykin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9285246

14 November 2024

R. Mayer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9285246

14 November 2024

M. Shinitzky

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9285246

14 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9285246

14 November 2024

publication date

1 August 1997

1 reference

13 February 2018

August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9285246

full work available at URL

14 November 2024

https://api.elsevier.com/content/article/PII:S0162310997000374?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

https://api.elsevier.com/content/article/PII:S0162310997000374?httpAccept=text/plain

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

14 November 2024

1 reference

13 February 2018

volume

1 reference

13 February 2018

issue

1 reference

13 February 2018

page(s)

75-86

1 reference

13 February 2018

Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8/DR3 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Important issues in the drug treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Serum immunoglobulin concentrations in patients admitted to an acute psychiatric in-patient service

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Depressant effects of major tranquillizers on contact hypersensitivity to picryl chloride in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Clinical and laboratory evidence of autoimmunity in acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Decreased interleukin-2 production in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Antiseptal brain antibody in IgG of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Increased prevalence of antibrain antibodies in the sera from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

The genetics of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Therapeutic effects of clozapine. A 4-year follow-up of a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Human parvovirus B19 infection in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Schizophrenia and autoimmunity--a possible etiological mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Lymphocyte subpopulations in peripheral blood from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Scenarios for a viral etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Immunogenetics and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Serum interleukin-6 in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Megabore capillary gas-liquid chromatographic method with nitrogen-phosphorus selective detection for the assay of haloperidol and reduced haloperidol in serum: results of therapeutic drug-monitoring during acute therapy of eight schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900037-4

7 January 2021

H gene theory of inherited autoimmune disease

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

T lymphocytes in schizophrenia

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

An example of European multicenter trials: multispectral analysis of clozapine

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

Is schizophrenia an autoimmune disease? A review

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

Effects of Psychotropic Drugs on DNA Synthesis in Cultured Lymphocytes

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

Autoimmune model of schizophrenia with special reference to antibrain antibodies

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

Neuroleptic affinities for human brain receptors and their use in predicting adverse effects

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

Aspects of humoral and cellular immunity in schizophrenia

14 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0162-3109(97)00037-4

14 November 2024

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018